Westphal Christoph H Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
96
Insider Buys Sum
$27.25M
Insider Sells Quantity
1
Insider Sells Sum
$2.94M

Insider Activity of Westphal Christoph H

Biography of Westphal Christoph H

No biography is available at this moment.

2021-07-20PurchaseTScan Therapeutics, Inc.
TCRX
10 percent owner
133,333
0.7856%
$15.00$2M-54.29%
2015-01-28PurchaseVerastem, Inc.
VSTM
Executive Chairman
2.46M
6.3765%
$6.50$16M-4.85%
2014-12-19PurchaseVerastem, Inc.
VSTM
Executive Chairman
3,000
0.0117%
$8.50$25,500-10.54%
2014-05-14PurchaseVerastem, Inc.
VSTM
Executive Chairman
4,000
0.0154%
$7.56$30,240+17.25%
2014-03-07PurchaseTempest Therapeutics, Inc.
TPST
100,000
0.4251%
$10.00$1M+37.84%
2013-11-18PurchaseVerastem, Inc.
VSTM
2,000
0.0095%
$9.60$19,204+4.93%
2013-09-11PurchaseTempest Therapeutics, Inc.
TPST
4,850
0.0198%
$10.53$51,071-14.25%
2013-06-07PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
2,000
0.0094%
$9.06$18,112+32.3%
2013-05-21PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
1,600
0.0078%
$9.24$14,786+34.55%
2013-05-03PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
1,600
0.0078%
$9.83$15,725+26.2%
2013-04-17PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
1,600
0.0077%
$9.53$15,248+29.41%
2013-03-21PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
1,600
0.0076%
$9.04$14,464+33.39%
2013-03-05PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
1,600
0.008%
$9.47$15,152+30.01%
2013-01-29PurchaseVerastem, Inc.
VSTM
Chief Executive Officer
600
0.0029%
$10.00$6,000+6.27%
2013-01-02PurchaseVerastem, Inc.
VSTM
President and C.E.O.
1,600
0.0077%
$9.73$15,568+5.91%
2004-05-27PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director, 10 percent owner
312,500
4.4585%
$6.00$1.88M+16.38%
Total: 16
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.